Norges Bank
ABVX

Norges Bank’s Abivax ABVX Stock Holding History

Norges Bank’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$147M Buy
+1,100,000
New +$124M 0.01% 640

Other funds holding ABVX

HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $646M AUM 291.07% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $295M AUM 40.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Norges Bank's ABVX Position: Q2 2026 in Review

Norges Bank opened a new position in Abivax (ABVX) in Q2 2026: 1,100,000 shares worth $147M. The stake represents 0.01% of the portfolio and ranks #640 among its holdings.

125 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Norges Bank held 1,100,000 shares of Abivax worth $147M as of Q2 2026.
  • Abivax was a new Norges Bank position in Q2 2026.
  • Abivax made up 0.01% of Norges Bank's portfolio in Q2 2026, its #640 holding.
  • 125 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.